Côte d'Ivoire vs Togo: Share of pregnant women with HIV that receive antiretroviral therapy
Côte d'Ivoire
88.0%
in 2024
Togo
87.0%
in 2024
Côte d'Ivoire rank
31st
Togo rank
33rd
Share of pregnant women with HIV that receive antiretroviral therapy over time
- Côte d'Ivoire
- Togo
How they compare
Côte d'Ivoire currently reports 88.0% against 87.0% in Togo, a difference of 1.0%.
The two have swapped places 7 times across 25 shared years of data; in 2000 it was Togo ahead.
Côte d'Ivoire ranks 31st and Togo ranks 33rd of 84 countries.
Across the 3 decades both report, Côte d'Ivoire averaged higher in 2 and Togo in 1.
Head to head by decade
| Decade | Côte d'Ivoire | Togo | Difference | Ahead |
|---|---|---|---|---|
| 2000s | 13.0% | 7.3% | 5.7% | Côte d'Ivoire |
| 2010s | 75.3% | 83.4% | 8.1% | Togo |
| 2020s | 90.6% | 85.4% | 5.2% | Côte d'Ivoire |
Averages of every year both report within each decade.
Frequently asked questions
- Which has higher share of pregnant women with hiv that receive antiretroviral therapy, Côte d'Ivoire or Togo?
- Côte d'Ivoire, at 88.0% against 87.0% in Togo as of 2024.
- What is the difference in share of pregnant women with hiv that receive antiretroviral therapy between Côte d'Ivoire and Togo?
- 1.0%, with Côte d'Ivoire ahead.
- How many years of comparable data are there for Côte d'Ivoire and Togo?
- 25 years are reported by both, from 2000 to 2024.
- How do Côte d'Ivoire and Togo rank globally for share of pregnant women with hiv that receive antiretroviral therapy?
- Côte d'Ivoire ranks 31st and Togo ranks 33rd of 84 countries.
- Where does this data come from?
- UNAIDS estimates, via World Bank (2026) – processed by Our World in Data, published as Share of pregnant women with HIV that receive antiretroviral therapy. Statizoid refreshes it automatically from the source and publishes the full history for both places.
Individual pages
About this data
Antiretroviral medicine is used to prevent mother-to-child transmission of HIV.